What's Happening?
Brazil's National Technical Biosafety Commission (CTNBio) has approved a new genetically modified (GM) soybean event developed by the Brazilian biotechnology unit of Beijing Dabeinong (DBN) Technology Group, a major Chinese agricultural conglomerate.
The approval, dated October 12, covers a three-way stacked soybean, designated DBN9004 x DBN8002 x DBN8205. This GM soybean combines two herbicide-tolerance genes with three insect-resistance genes in a single seed. The herbicide-tolerance genes, epsps and pat, provide resistance to glyphosate and glufosinate ammonium, respectively. The insect-resistance genes, cry1Ac, cry2Ab2, and mVip3Aa, are derived from the soil bacterium Bacillus thuringiensis (Bt) and target pests like fall armyworm, southern armyworm, and cotton bollworm. This approval signifies a growing presence of Chinese agricultural biotechnology companies in Brazil, a market traditionally dominated by Western seed and chemical companies.
Why It's Important?
This approval is significant for the agricultural sector, particularly in Brazil, the world's largest soybean producer and exporter. The stacked-trait GM soybean offers Brazilian growers enhanced protection against key lepidopteran pests, such as the fall armyworm, which has shown increasing resistance to older single-gene Bt traits. The combination of dual herbicide tolerance with multiple insect-resistance genes provides a more robust solution for weed and pest management, potentially reducing crop losses and the need for multiple pesticide applications. This development also marks a shift in the global agricultural biotechnology landscape, as Chinese companies expand their influence in major agricultural markets. For U.S. agriculture, this could mean increased competition in the global soybean market and a potential shift in the dynamics of agricultural technology development and adoption.
What's Next?
While CTNBio approval is a regulatory milestone, it does not immediately translate to commercial availability. The new soybean event will require additional seed multiplication and registration steps in Brazil before it can be widely adopted by growers, a process that typically spans one or more growing seasons. DBN's continued push into stacked-trait soybeans suggests further trait launches in South America's soybean belt are likely. This could lead to increased competition in the trait-licensing business, which has historically been concentrated among companies like Bayer, Corteva, Syngenta, and BASF. The long-term implications could include a diversification of seed suppliers and potentially more competitive pricing for GM soybean seeds in the global market.
Beyond the Headlines
The approval of this stacked-trait GM soybean highlights the ongoing evolution of agricultural biotechnology and its role in addressing challenges like pest resistance and weed control. The strategy of combining multiple genes for both herbicide and insect resistance in a single plant reflects a sophisticated approach to resistance management, aiming to extend the efficacy of these technologies. This development also underscores the increasing global interconnectedness of agricultural research and development, with Chinese companies making significant inroads into international markets. Ethical considerations surrounding genetically modified organisms, including their environmental impact and potential effects on biodiversity, will likely remain a subject of ongoing debate and scrutiny as these technologies become more widespread.
